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Introduction
Primary carcinoma of Bartholin’s gland is a rare
malignant tumor arising from the posterior half of the
vulvar region. Primary adenocarcinoma of Bartholin’s
gland represents less than 1% of all genital malignan-
cies and 2–7% of all vulvar carcinomas. Adenoid cystic
carcinoma (ACC) of Bartholin’s gland is a distinctive
entity of vulvar malignancy, accounting for 10–15% of
Bartholin’s gland carcinomas [1]. The clinical course of
ACC is protracted, with a tendency for perineural and
local invasion [2]. Distant metastasis may appear several
months or years after local recurrence.
Case Report
A 49-year-old woman, gravida 4, para 3, presented with
a painless lump in her left labial area for about 2 years.
Initially, she consulted a local gynecologist and a Bar-
tholin’s cyst was diagnosed. Aspiration was per-
formed but the mass persisted. She was referred to
our hospital in August 2002 due to the increasing size
of the lump.
The lump was incised and drained. Histology of the
biopsy specimen confirmed ACC of Bartholin’s gland.
The patient underwent radical vulvectomy with inguinal
lymph node dissection. The surgical specimen revealed
the same histologic findings as the biopsy. The surgical
margins and bilateral inguinal lymph nodes were free of
tumor. The postoperative course was uneventful. The
patient has been under observation for 18 months
without any recurrence or metastasis.
Discussion
Bartholin’s gland is located deep in the bulbospongiosis
muscle, adjacent to the introitus. The diagnostic criteria
for primary Bartholin’s gland carcinoma must include
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anatomic position in the Bartholin’s gland with intact
overlying skin. This is an adaptation of the stricter
criteria of Honan [3].
Adenocarcinoma arising from the mucin-secreting
columnar epithelial cells of the acini accounts for
approximately 40% of Bartholin’s gland carcinoma.
Squamous cell carcinoma arising from the squamous
epithelium at the vestibular orifice accounts for an-
other 40% [4]. Other types include ACC (10–15%),
transitional cell carcinoma (< 5%), poorly differentiated
adenocarcinoma, and clear cell carcinoma [5,6].
The age at presentation with Bartholin’s gland
carcinoma is 50–60 years. The tumor generally pres-
ents as a painless lump in the posterior part of the
labium major [7,8]. Other symptoms include bleed-
ing, pruritus, and pain. The reported duration of pres-
enting symptoms ranges from 3 weeks to 17 months
[9,10]. The interval from the onset of symptoms to
definite diagnosis is not correlated with tumor size,
stage of disease, or outcome [9]. Most patients are
initially diagnosed with Bartholin’s cyst or abscess
and are treated with incision and drainage or mar-
supialization. Failure of resolution of the mass ulti-
mately leads to biopsy and appropriate diagnosis.
The extreme rarity of Bartholin’s gland carcinoma
makes it difficult to perform large studies to define
the optimal treatment. Various therapeutic modalities
have been suggested, including wide excision, radical
hemivulvectomy, radical vulvectomy, and pelvic
exenteration. Whether unilateral or bilateral inguinal
lymphadenectomy is necessary is controversial. Sur-
gical resection with adequate margins may disrupt the
function of adjacent organs. Morbidity after such radi-
cal procedures is considerable, although reconstruction
may be possible [11,12]. Chemoradiation plus con-
servative surgery has been proposed as a therapeutic
alternative to extensive radical surgery [9,11–14].
ACC of Bartholin’s gland is similar to ACCs derived
from salivary glands, the upper respiratory tract, and
breast. The most common type of ACC of Bartholin’s
gland has a cribriform pattern, characterized by nests
containing hyalinized basement membrane-like mate-
rial [4]. Some ACCs show a tubular pattern of growth,
whereas others are mainly solid. The pattern of growth
is used as a grading system in salivary glands [15]. The
tubular pattern is regarded as the best differentiated
and the type with most favorable prognosis [16]. The
solid type is associated with a higher incidence of
metastasis and a significantly lower survival rate.
Local recurrence can be expected even in the case of
negative surgical margins. Copeland et al [17] and Lelle
et al [18] have reported 10-year progression-free in-
tervals of 38% and 33%, respectively, compared to
survival rates of 59% and 100%, respectively. This
confirms a protracted, although malignant, clinical
course with this disease entity.
Although uncommon, Bartholin’s gland carcinoma
should be suspected when excess induration or necrotic
debris is present and when a Bartholin’s cyst or abscess
is unresponsive to conventional therapy, especially in
perimenopausal and postmenopausal women.
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